Islet Transplantation and Diabetes Management

Pancreatic islet transplantation has emerged as a transformative approach in restoring endogenous insulin production for individuals with insulin‐dependent diabetes mellitus. By isolating and implanting clusters of insulin‐producing β cells into immunoprivileged sites such as the liver or subcutaneous space, this therapy aims to achieve long‐term glycaemic control without the burdens of intensive insulin therapy. Advances in donor procurement, islet isolation techniques and immunosuppressive regimens have improved initial engraftment, yet challenges persist in ensuring sustained graft viability. Among these, early post‐transplant losses driven by hypoxia, inflammatory reactions and fibrotic overgrowth compromise functional β‐cell mass. Bioengineering innovations, including semi‐permeable encapsulation devices and vascular scaffolds, seek to mitigate immune rejection and revascularisation deficits. Complementing procedural refinements, emerging research into stem‐cell‐derived β‐cell sources and bioactive matrices holds promise for scalable and durable cell therapies. Together, these developments underpin a global effort to translate islet transplantation into a routine clinical solution for diabetes management.

Research from Nature Portfolio

Recent clinical studies have explored device‐based delivery of stem‐cell‐derived β cells, demonstrating that optimised encapsulation membranes with tailored porosity can improve graft survival and insulin output in patients with type 1 diabetes. Early‐phase trials report modest increases in meal‐stimulated C‐peptide levels and enhanced time‐in‐range metrics on continuous glucose monitoring, highlighting proof‐of‐concept for microencapsulation strategies. Parallel preclinical work has introduced zwitterionic modifications to alginate matrices, effectively reducing fibrotic overgrowth and foreign body reactions in large animal models, thereby preserving islet viability. Additionally, engineered microvascular networks fabricated via self‐assembly methods have been shown to promote rapid and robust revascularisation of transplanted islets in subcutaneous sites, facilitating sustained normoglycaemia over several months in diabetic rodent models. Together, these advances underscore a multifaceted bioengineering approach that integrates immunoisolation, immunomodulation and vascularisation to enhance the efficacy of islet transplantation.

Islet Transplantation and Diabetes Management publication trend

The graph below shows the total number of articles in islet transplantation and diabetes management across all publications each year (not limited to Nature Index journals).

Technical terms

Islet transplantation: The process of isolating pancreatic islets, containing insulin‐producing β cells, and implanting them into a recipient to restore insulin production.

β cell: A pancreatic endocrine cell type responsible for synthesising and secreting insulin in response to blood glucose levels.

Encapsulation: The technique of enclosing cells within a semi‐permeable membrane or matrix to protect grafts from immune attack while allowing nutrient and insulin exchange.

Instant blood‐mediated inflammatory reaction (IBMIR): An acute immune response characterised by coagulation and complement activation that damages transplanted islets upon contact with blood.

Alginate: A biocompatible polysaccharide derived from seaweed commonly used to form hydrogels for cell encapsulation due to its gentle gelation and permeability properties.

References

1. Encapsulated stem cell–derived β cells exert glucose control in patients with type 1 diabetes. Nature Biotechnology (2023).
2. Isolated Human Islets Trigger an Instant Blood Mediated Inflammatory Reaction: Implications for Intraportal Islet Transplantation as a Treatment for Patients with Type 1 Diabetes. Upsala Journal of Medical Sciences (2000).
3. Zwitterionically modified alginates mitigate cellular overgrowth for cell encapsulation. Nature Communications (2019).
4. Cell Encapsulation Within Alginate Microcapsules: Immunological Challenges and Outlook. Frontiers in Bioengineering and Biotechnology (2019).
5. Extracellular matrix molecules and their potential contribution to the function of transplanted pancreatic islets. Diabetologia (2018).
6. Engineering transferrable microvascular meshes for subcutaneous islet transplantation. Nature Communications (2019).